Live Breaking News & Updates on Telos Capital Management Inc
Stay updated with breaking news from Telos capital management inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....
Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....
Epoch Investment Partners Inc. grew its holdings in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 82.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 589,070 shares of the medical research company’s stock after purchasing an additional 266,292 […] ....
Peapack Gladstone Financial Corp raised its position in The Walt Disney Company (NYSE:DIS – Free Report) by 1.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 332,870 shares of the entertainment giant’s stock after acquiring an additional 5,085 […] ....
CIBC Private Wealth Group LLC grew its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 197.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,446,758 shares of the medical research company’s stock after acquiring […] ....